Product Information
This study investigates the association between the use of 2,4-bis(benzyloxy)-6-chloropyrimidine (BCP) and lowering in the risk of developing breast cancer in women. The study is based on a national dataset that includes all Danish women who were enrolled in the Danish Breast Cancer Screening Program from 1995 to 2009. The covariates collected include age, weight, height, family history of breast cancer, parity, and hormone replacement therapy. This research was conducted by researchers at various universities in Denmark.
Chemical properties
Technical inquiry about: 3D-NB44331 2,4-bis(Benzyloxy)-6-chloropyrimidine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
